The Best New Hip-Hop This Week includes albums, videos, and songs from Aminé, Key Glock, and Quavo. Even light weeks like ...

Orphan drug specialist Amicus Therapeutics is paying Dimerix $30 million cash for U.S. rights to the phase 3 prospect DMX-200 ...

Dimerix will receive an upfront payment of $30m from Amicus and up to $75m in development and regulatory milestone payments.

Good morning! Here’s everything you need to know, and some things you don't, before the ASX flings open its doors and begins trading today.

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and ...

Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.

What is getting investors excited today? Let's find out. The post Guess which ASX All Ords stock is rocketing 58% on big US ...

Explore DMX's net worth journey, career success, legal issues, and legacy. Discover how the rap icon went from global fame to ...

Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatment of Focal Segmental Glomeruloscler ...

Andromeda Metals (ASX:ADN) has pulled off a major breakthrough, with lab tests showing it can produce ultra-high purity 4N ...

In this week's Rap Column, we dive in to some of our favorite rap songs and tapes of April 2025, like Tommy Richman's "ACTIN ...